Pharmacological Research · 2024 · 17 citations · 64 references
Life SciencesCell BiologyOncologyEndocytosisIntracellular TransportMolecular OncologyEndosomal SortingEndosomal TraffickingIntracellular TraffickingLate EndosomesReceptor InternalizationReceptor-mediated EndocytosisCell Therapy EfficacyEndocytic InternalizationEndocytic Pathway RegulationEndocytic Trafficking Of ReceptorsEndocytosis PathwaysReceptors
The endocytic trafficking pathway is a highly organized cellular program responsible for the regulation of membrane components and uptake of extracellular substances. Molecules internalized into the cell through endocytosis will be sorted for degradation or recycled back to membrane, which is determined by a series of sorting events. Many receptors, enzymes, and transporters on the membrane are strictly regulated by endocytic trafficking process, and thus the endocytic pathway has a profound effect on cellular homeostasis. However, the endocytic trafficking process is typically dysregulated in cancers, which leads to the aberrant retention of receptor tyrosine kinases and immunosuppressive molecules on cell membrane, the loss of adhesion protein, as well as excessive uptake of nutrients. Therefore, hijacking endocytic trafficking pathway is an important approach for tumor cells to obtain advantages of proliferation and invasion, and to evade immune attack. Here, we summarize how dysregulated endocytic trafficking process triggers tumorigenesis and progression from the perspective of several typical cancer hallmarks. The impact of endocytic trafficking pathway to cancer therapy efficacy is also discussed.
64
CMTM6 maintains the expression of PD-L1 and regulates anti-tumour immunity
Marian L. Burr, Christina E. Sparbier, Yih-Chih Chan et al. · Nature · 2017 · 950 citations · Full text
Medicine, Immunology, Oncology +12
E-cadherin is required for metastasis in multiple models of breast cancer
Veena Padmanaban, Ilona Krol, Yasir Suhail et al. · Nature · 2019 · 874 citations · Full text
Medicine, Cancer Biology, Oncology +13
Tepotinib in Non–Small-Cell Lung Cancer with <i>MET</i> Exon 14 Skipping Mutations
Paul K. Paik, Enriqueta Felip, Rémi Veillon et al. · New England Journal of Medicine · 2020 · 854 citations · Full text
Medicine, Oncology, Pharmacology +15